LTO / BTC

LEVER / TRY

LEVER / USDT

LTO / USDT

GALA / BTC

GUN / FDUSD

PEOPLE / BTC

FIDA / BTC

FIDA / USDT

FIDA / TRY

BEL / BTC

BEL / TRY

BEL / USDT

HFT / BTC

CTK / BTC

SAHARA / BNB

MOVE / BTC

NEWT / BNB

SAHARA / USDT

SAHARA / TRY

ELLENBARRIE INDUS GASES L

GLOBE CIVIL PROJECTS LTD

CAPITAL TRUST LTD

GABRIEL INDIA LTD

TAMILNADU TELECOMMUNICATI

DANGEE DUMS LIMITED

JEENA SIKHO LIFECARE LTD

ZOTA HEALTH CARE LIMITED

FILATEX FASHIONS LIMITED

CENTURY EXTRUSIONS LTD

PREMIUM PLAST LIMITED

GACM TECHNOLOGIES LIMITED

BOMBAY METRICS S C LTD

ITALIAN EDIBLES LIMITED

HB STOCKHOLDINGS LIMITED

FORCE MOTORS LIMITED

JAYASWAL NECO INDUSTR LTD

SERVICE CARE LIMITED

COROMANDEL INTERNTL. LTD

GVP INFOTECH LIMITED

Click here to get full coverage on Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues - simplywall.st

Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues  simplywall.st

Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues - simplywall.st

Click here to get full coverage on Zota Beach Resort sets the scene for local business connections - Your Observer

Zota Beach Resort sets the scene for local business connections  Your Observer

Zota Beach Resort sets the scene for local business connections - Your Observer

Click here to get full coverage on Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44M - Neurology live

Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44M  Neurology live

Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44M - Neurology live

Click here to get full coverage on Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients - Clinical Trials Arena

Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients  Clinical Trials Arena

Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients - Clinical Trials Arena

Click here to get full coverage on Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip - PR Newswire

Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip  PR Newswire

Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip - PR Newswire

Click here to get full coverage on Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Del-Zota for Duchenne Muscular Dystrophy  CGTLive®

Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Click here to get full coverage on Del-zota increases dystrophin in DMD patients, new trial data show - Muscular Dystrophy News

Del-zota increases dystrophin in DMD patients, new trial data show  Muscular Dystrophy News

Del-zota increases dystrophin in DMD patients, new trial data show - Muscular Dystrophy News

Click here to get full coverage on Planning Commission postpones vote on HB 443 ZOTA - The Lexington Times

Planning Commission postpones vote on HB 443 ZOTA  The Lexington Times

Planning Commission postpones vote on HB 443 ZOTA - The Lexington Times

Click here to get full coverage on Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update - FirstWord Pharma

Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update  FirstWord Pharma

Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update - FirstWord Pharma

Click here to get full coverage on Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD - Neurology live

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD  Neurology live

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD - Neurology live

Click here to get full coverage on Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst - Fierce Biotech

Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst  Fierce Biotech

Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst - Fierce Biotech

Click here to get full coverage on Zota Health Care expands Davaindia Network to 1,413 operational stores - Indian Pharma Post

Zota Health Care expands Davaindia Network to 1,413 operational stores  Indian Pharma Post

Zota Health Care expands Davaindia Network to 1,413 operational stores - Indian Pharma Post

Click here to get full coverage on Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy - Managed Healthcare Executive

Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy  Managed Healthcare Executive

Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy - Managed Healthcare Executive

Click here to get full coverage on Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 - BioSpace

Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025  BioSpace

Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 - BioSpace

Click here to get full coverage on Avidity Biosciences Accelerates Path to First Drug Approval, Expands Leadership for 2025 Launch - Stock Titan

Avidity Biosciences Accelerates Path to First Drug Approval, Expands Leadership for 2025 Launch  Stock Titan

Avidity Biosciences Accelerates Path to First Drug Approval, Expands Leadership for 2025 Launch - Stock Titan

Click here to get full coverage on Michael Flanagan, PhD, on Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Michael Flanagan, PhD, on Del-Zota for Duchenne Muscular Dystrophy  CGTLive®

Michael Flanagan, PhD, on Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Click here to get full coverage on Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 - PR Newswire

Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44  PR Newswire

Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 - PR Newswire

Click here to get full coverage on Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy - Neurology live

Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy  Neurology live

Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy - Neurology live

Click here to get full coverage on Zota Health Care expands Davaindia network to 1,530 stores - Indian Pharma Post

Zota Health Care expands Davaindia network to 1,530 stores  Indian Pharma Post

Zota Health Care expands Davaindia network to 1,530 stores - Indian Pharma Post

Click here to get full coverage on Behind the castle gates: Florida sand sculptor gives a glimpse of his craft - Your Observer

Behind the castle gates: Florida sand sculptor gives a glimpse of his craft  Your Observer

Behind the castle gates: Florida sand sculptor gives a glimpse of his craft - Your Observer

Click here to get full coverage on Investors Appear Satisfied With Zota Health Care Limited's (NSE:ZOTA) Prospects As Shares Rocket 33% - simplywall.st

Investors Appear Satisfied With Zota Health Care Limited's (NSE:ZOTA) Prospects As Shares Rocket 33%  simplywall.st

Investors Appear Satisfied With Zota Health Care Limited's (NSE:ZOTA) Prospects As Shares Rocket 33% - simplywall.st

Click here to get full coverage on Zota Health Car Standalone March 2025 Net Sales at Rs 77.93 crore, up 64.59% Y-o-Y - Moneycontrol

Zota Health Car Standalone March 2025 Net Sales at Rs 77.93 crore, up 64.59% Y-o-Y  Moneycontrol

Zota Health Car Standalone March 2025 Net Sales at Rs 77.93 crore, up 64.59% Y-o-Y - Moneycontrol

Click here to get full coverage on Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease - Frontiers

Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease  Frontiers

Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease - Frontiers

Click here to get full coverage on Bucharest listening bar created in "landmark of Romanian modernism" - Dezeen

Bucharest listening bar created in "landmark of Romanian modernism"  Dezeen

Bucharest listening bar created in "landmark of Romanian modernism" - Dezeen

Click here to get full coverage on Zota Health Care Q2 FY25 revenue up 48.6% - Indian Pharma Post

Zota Health Care Q2 FY25 revenue up 48.6%  Indian Pharma Post

Zota Health Care Q2 FY25 revenue up 48.6% - Indian Pharma Post

Click here to get full coverage on Analysts dig into details of Avidity's DMD win, revealing nuances in strong data - Fierce Biotech

Analysts dig into details of Avidity's DMD win, revealing nuances in strong data  Fierce Biotech

Analysts dig into details of Avidity's DMD win, revealing nuances in strong data - Fierce Biotech

Click here to get full coverage on Market Trading Guide: MTAR Tech, Zota Health among 4 stock recommendations for Wednesday - The Economic Times

Market Trading Guide: MTAR Tech, Zota Health among 4 stock recommendations for Wednesday  The Economic Times

Market Trading Guide: MTAR Tech, Zota Health among 4 stock recommendations for Wednesday - The Economic Times

Click here to get full coverage on Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug - Endpoints News

Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug  Endpoints News

Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug - Endpoints News

Click here to get full coverage on Avidity eyes 2025 BLA on back of positive DMD data - BioWorld MedTech

Avidity eyes 2025 BLA on back of positive DMD data  BioWorld MedTech

Avidity eyes 2025 BLA on back of positive DMD data - BioWorld MedTech

Click here to get full coverage on Zota Health Care (NSE:ZOTA) surges 24% this week, taking five-year gains to 460% - simplywall.st

Zota Health Care (NSE:ZOTA) surges 24% this week, taking five-year gains to 460%  simplywall.st

Zota Health Care (NSE:ZOTA) surges 24% this week, taking five-year gains to 460% - simplywall.st

Click here to get full coverage on Davaindia accelerates expansion with 1,165 operational stores - Indian Pharma Post

Davaindia accelerates expansion with 1,165 operational stores  Indian Pharma Post

Davaindia accelerates expansion with 1,165 operational stores - Indian Pharma Post

Click here to get full coverage on Family of Zota murder victim files wrongful death lawsuit - Sarasota Herald-Tribune

Family of Zota murder victim files wrongful death lawsuit  Sarasota Herald-Tribune

Family of Zota murder victim files wrongful death lawsuit - Sarasota Herald-Tribune

Click here to get full coverage on Market Trading Guide: Zota Health, Thyrocare are stock recommendations for Tuesday - The Economic Times

Market Trading Guide: Zota Health, Thyrocare are stock recommendations for Tuesday  The Economic Times

Market Trading Guide: Zota Health, Thyrocare are stock recommendations for Tuesday - The Economic Times

Click here to get full coverage on Q&A: Ami Zota on the Hidden Dangers in Beauty Products—and Why Women of Color Are Particularly at Risk - Inside Climate News

Q&A: Ami Zota on the Hidden Dangers in Beauty Products—and Why Women of Color Are Particularly at Risk  Inside Climate News

Q&A: Ami Zota on the Hidden Dangers in Beauty Products—and Why Women of Color Are Particularly at Risk - Inside Climate News

Click here to get full coverage on Zota Health Care reports consolidated net loss of Rs 12.89 crore in the March 2025 quarter - Business Standard

Zota Health Care reports consolidated net loss of Rs 12.89 crore in the March 2025 quarter  Business Standard

Zota Health Care reports consolidated net loss of Rs 12.89 crore in the March 2025 quarter - Business Standard

Click here to get full coverage on Zota resort killings: Second suspect arrested 6 years after 2 employees shot to death - FOX 13 Tampa Bay

Zota resort killings: Second suspect arrested 6 years after 2 employees shot to death  FOX 13 Tampa Bay

Zota resort killings: Second suspect arrested 6 years after 2 employees shot to death - FOX 13 Tampa Bay

Click here to get full coverage on Tourism groups work to boost tourism for season after two hurricanes - Your Observer

Tourism groups work to boost tourism for season after two hurricanes  Your Observer

Tourism groups work to boost tourism for season after two hurricanes - Your Observer

Click here to get full coverage on Zota Health Care expands retail pharmacy network to 1,294 stores - BusinessLine

Zota Health Care expands retail pharmacy network to 1,294 stores  BusinessLine

Zota Health Care expands retail pharmacy network to 1,294 stores - BusinessLine

Click here to get full coverage on Alleged getaway driver in Longboat Key Zota Resort double-homicide charged with murder - Bradenton Herald

Alleged getaway driver in Longboat Key Zota Resort double-homicide charged with murder  Bradenton Herald

Alleged getaway driver in Longboat Key Zota Resort double-homicide charged with murder - Bradenton Herald

Click here to get full coverage on Zota Health Care launched B2C online portal ‘davaindia’ - Indian Pharma Post

Zota Health Care launched B2C online portal ‘davaindia’  Indian Pharma Post

Zota Health Care launched B2C online portal ‘davaindia’ - Indian Pharma Post

Click here to get full coverage on Zota murder case - ABC7 WWSB

Zota murder case - ABC7 WWSB

Click here to get full coverage on Expert Testimony Leads to Law on Toxic-Free Cosmetics - Columbia University Mailman School of Public Health

Expert Testimony Leads to Law on Toxic-Free Cosmetics  Columbia University Mailman School of Public Health

Expert Testimony Leads to Law on Toxic-Free Cosmetics - Columbia University Mailman School of Public Health

Click here to get full coverage on Interview: Costain CEO credits long-term agreements for company’s £1.5bn order book increase - New Civil Engineer

Interview: Costain CEO credits long-term agreements for company’s £1.5bn order book increase  New Civil Engineer

Interview: Costain CEO credits long-term agreements for company’s £1.5bn order book increase - New Civil Engineer

Click here to get full coverage on Second suspect arrested for 2017 Longboat murders at Zota resort - Your Observer

Second suspect arrested for 2017 Longboat murders at Zota resort  Your Observer

Second suspect arrested for 2017 Longboat murders at Zota resort - Your Observer

Click here to get full coverage on Six-year hunt for Longboat double-homicide suspects heats up - Your Observer

Six-year hunt for Longboat double-homicide suspects heats up  Your Observer

Six-year hunt for Longboat double-homicide suspects heats up - Your Observer

Click here to get full coverage on Sara and Zota Named at The Bay - SRQ Magazine

Sara and Zota Named at The Bay  SRQ Magazine

Sara and Zota Named at The Bay - SRQ Magazine

Click here to get full coverage on Zota Beach Resort debuts on Longboat Key - Travel Weekly

Zota Beach Resort debuts on Longboat Key  Travel Weekly

Zota Beach Resort debuts on Longboat Key - Travel Weekly

Click here to get full coverage on Minority Women Exposed to Toxic Chemicals in Beauty Products - GW Today

Minority Women Exposed to Toxic Chemicals in Beauty Products  GW Today

Minority Women Exposed to Toxic Chemicals in Beauty Products - GW Today

Click here to get full coverage on First Bite: Breakfast at Zota Beach Resort on Longboat Key - Sarasota Magazine

First Bite: Breakfast at Zota Beach Resort on Longboat Key  Sarasota Magazine

First Bite: Breakfast at Zota Beach Resort on Longboat Key - Sarasota Magazine

Click here to get full coverage on Ocean Properties buys out Zota Beach Resort partner - Business Observer

Ocean Properties buys out Zota Beach Resort partner  Business Observer

Ocean Properties buys out Zota Beach Resort partner - Business Observer

Click here to get full coverage on Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend - Stuart Magazine

Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend  Stuart Magazine

Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend - Stuart Magazine

Click here to get full coverage on Is Zota Health Care (NSE:ZOTA) A Risky Investment? - simplywall.st

Is Zota Health Care (NSE:ZOTA) A Risky Investment?  simplywall.st

Is Zota Health Care (NSE:ZOTA) A Risky Investment? - simplywall.st

Click here to get full coverage on Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend - Fort Lauderdale Illustrated

Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend  Fort Lauderdale Illustrated

Longboat Key’s Zota Beach Resort Is The Quintessential Place For A Quiet Getaway Weekend - Fort Lauderdale Illustrated

Click here to get full coverage on Avidity CEO says it’s ‘full steam ahead’ in DMD as stock rallies on Phase 1/2 win - Endpoints News

Avidity CEO says it’s ‘full steam ahead’ in DMD as stock rallies on Phase 1/2 win  Endpoints News

Zota Health Care LImited (ZOTA)

Price Chart

Key Statistics

Technicals

About ZOTA

Latest News

Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues - simplywall.st

Zota Beach Resort sets the scene for local business connections - Your Observer

Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44M - Neurology live

Advanced Charts

Top Gainers

Top Losers